The Medical Devices (Amendment) (Great Britain) Regulations 2025 mark a significant step in the UK’s post-Brexit regulation. These amendments modify the Medical Devices Regulations 2002 to ensure continued supervision of medical devices in England, Wales, and Scotland. This strategy is aimed at safeguarding patient safety as the UK transitions to an independent regulatory framework.
With several EU-derived regulations scheduled to expire in May 2025, leading to compliance gaps for manufacturers and healthcare providers. However, following a public consultation, the UK government decided to retain four key pieces of assimilated EU law, preventing regulatory uncertainty.
The UK’s Post-Brexit Medical Device Regulation
Since leaving the EU, the UK has been gradually developing its own regulatory system for medical devices, moving away from the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). The Medicines and Healthcare products Regulatory Agency (MHRA) has been leading this transition, with the goal of establishing a UK-specific framework that maintains high safety standards while improving market access.
However, this shift requires temporary measures to prevent disruptions. Several EU-derived laws were initially set to expire in May 2025 under the Retained EU Law (Revocation and Reform) Act 2023. The 2025 Amendment ensures that critical regulations remain in force until the UK finalizes its own rules.
Key Changes in the 2025 Amendment
The Medical Devices (Amendment) (Great Britain) Regulations 2025 primarily focus on retaining four EU regulations that were at risk of revocation:
By retaining these regulations, the UK avoids a regulatory gap, providing stability for manufacturers and ensuring patient safety.
Reasons for retaining these regulations
1. Public Consultation Findings
The UK Department of Health and Social Care (DHSC) conducted a consultation in late 2024, gathering feedback from:
Key takeaways:
2. Risk of Revocation Without Replacement
If these regulations had expired in May 2025, the UK could have faced:
The 2025 Amendment ensures a smooth transition while the MHRA finalizes the UK Medical Device Regulations.
Impact on Medical Device Manufacturers
1. Continued Compliance Under Existing Rules
2. Stability During UKCA Transition
3. No Disruption to Market Access
4. Future-Proofing for UK-Specific Regulations
Next Steps for Manufacturers:
Manufacturers should proactively monitor official guidance channels and assess how these changes may impact their technical documentation, quality systems, and market access strategies for the GB market. Staying informed and preparing in advance will help ensure a smooth transition to the UK's independent medical device regulations.
Conclusion
The Medical Devices (Amendment) (Great Britain) Regulations 2025 provide essential stability by ensuring that critical EU-derived laws remain in effect as the UK develops its own regulatory framework. By retaining these regulations that would have led to the expiration of several key EU- derived regulations on 25 th May and 26 th May 2025. This amendment by the government has prevented compliance gaps, protected patient safety, and given manufacturers additional time to adapt. This move allows manufacturers to continue operating under familiar frameworks while preparing for the forthcoming UK-specific regulations. Healthcare professionals can be reassured that essential safety and performance standards remain in place, safeguarding patient health.
The Medicines and Healthcare products Regulatory Agency (MHRA) plans to implement new UK Medical Device Regulations between 2026 and 2027, introducing measures such as implant cards, unique device identifiers, and an international reliance scheme for medical devices.
In the meantime, stakeholders should stay informed by monitoring MHRA updates, maintain compliance with existing EU-aligned regulations, engage with regulators through consultations, and proactively strategize for a seamless transition to the anticipated UK-specific regulation. This amendment not only ensures regulatory stability but also lays the foundation for a robust and independent medical device regulatory system in Great Britain
Reference: The Medical Devices (Amendment) (Great Britain) Regulations 2025
If you have any questions, contact us for expert support.
